IL6 and rheumatoid arthritis: Previous research predominantly focused on its anti-inflammatory characteristics, including inhibition of pro-inflammatory cytokines (e.g., IL-6, TNF-α) (Piao et al., 2021; Zhang et al., 2019) and induction of RA-FLS apoptosis (Lin et al., 2021).